Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D0LX8D
|
||||
Former ID |
DCL000478
|
||||
Drug Name |
AZD6918
|
||||
Indication | Advanced solid malignancies [ICD9: 140-199, 140-239, 210-229; ICD10:D10-D36, D3A] | Discontinued in Phase 1 | [548789] | ||
Company |
AstraZeneca
|
||||
Target and Pathway | |||||
Target(s) | Neurotrophic tyrosine kinase receptor 1 | Target Info | Inhibitor | [550288] | |
NetPath Pathway | IL2 Signaling Pathway | ||||
Pathway Interaction Database | Neurotrophic factor-mediated Trk receptor signaling | ||||
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.